See also this year's filing and all EDGAR filings for this company.
PDF Report 0000707511_2018_Regenerx_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000707511, Regenerx Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 217,150 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,171 |
| 3 | remainder_Assets | 5,752 |
| 4 | LiabilitiesCurrent | 2,153,089 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 2,190,276 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 1,409,057 |
| 9 | ResearchAndDevelopmentExpense | 174,619 |
| 10 | remainder_Expenses | 102,873 |
| 11 | remainder_Revenues | 49,403 |
| 12 | remainder_NetIncome | 1,872,079 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 227,073 |
| 1 | Liabilities | 4,343,365 |
| 2 | Expenses | 1,686,549 |
| 3 | Revenues | 49,403 |
| 4 | StockholdersEquity | -4,116,292 |
| 5 | NetIncome | 234,933 |
| 6 | ComprehensiveNetIncome | 234,933 |
| 7 | BaseVar | 4,089,234 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.82 |
| 9 | EconomicCapitalRatio | 0.438 |
Edgar->Model Mapping
Feature Distribution
Change over Time
